Smartleaf Asset Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.08K Buy
95
+92
+3,067% +$4.17K ﹤0.01% 2643
2026
Q2
$88 Hold
3
– – ﹤0.01% 3373
2026
Q1
$49 Hold
3
– – ﹤0.01% 3434
2025
Q4
$57 Buy
+3
New +$50 ﹤0.01% 3429
2025
Q2
– Sell
-27
Closed -$484 – 2770
2025
Q1
$484 Buy
+27
New +$582 ﹤0.01% 2704
2024
Q3
– Sell
-27
Closed -$388 – 2915
2024
Q2
$388 Buy
+27
New +$326 ﹤0.01% 2595

Other funds holding CDNA

Smartleaf Asset Management's CDNA Position: Q3 2026 in Review

Smartleaf Asset Management increased its CareDx (CDNA) stake by 3,067% in Q3 2026, buying an estimated $4.17K and bringing the position to 95 shares worth $6.08K. The position accounts for ﹤0.01% of the portfolio, ranked #2643.

Smartleaf Asset Management first reported a position in CDNA in Q2 2024 and has held it in 6 quarters since. 231 funds tracked by Wall St. Rank hold CDNA as of Q3 2026.

  • Smartleaf Asset Management held 95 shares of CareDx worth $6.08K as of Q3 2026.
  • Smartleaf Asset Management bought 92 CareDx shares in Q3 2026, an estimated $4.17K.
  • CareDx made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q3 2026, its #2643 holding.
  • Smartleaf Asset Management first reported a position in CareDx in Q2 2024 and has held it in 6 quarters since.
  • 231 funds tracked by Wall St. Rank held CareDx as of Q3 2026.

Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.